Literature DB >> 8671418

Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.

T Levy1, R Orvieto, R Homburg, D Peleg, A Dekel, Z Ben-Rafael.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is the most serious, life-threatening, iatrogenic complication of ovulation induction. The importance of excessive oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration as a predictor and factor in the pathophysiology of OHSS has been extensively studied and discussed. We present the case report of a woman with hypogonadotrophic hypogonadism who developed severe OHSS during ovulation induction with urinary human follicle stimulating hormone (FSH) and HCG in the presence of low circulating oestradiol concentrations. The implication of FSH treatment and complications in hypogonadotrophic hypogonadal patients, and the role of preovulatory oestradiol concentrations in the prediction of OHSS, are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671418     DOI: 10.1093/oxfordjournals.humrep.a019350

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?

Authors:  Raoul Orvieto
Journal:  J Assist Reprod Genet       Date:  2016-07-22       Impact factor: 3.412

2.  The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome.

Authors:  R Orvieto; A Achiron; R Margalit; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

3.  Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism.

Authors:  M Sönmezer; B Özmen; C S Atabekoglu; E G Papuccu; S Ozkavukcu; B Berker; R Pabuccu
Journal:  J Assist Reprod Genet       Date:  2012-05-01       Impact factor: 3.412

Review 4.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

Review 5.  Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.

Authors:  Kelly Comerford Wormer; Ayesha A Jangda; Farah A El Sayed; Katherine I Stewart; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-19       Impact factor: 2.435

6.  Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases.

Authors:  Ali Sami Gürbüz; Funda Göde; Fatma Kılıç; Zeynep Umay Gürbüz; Rüya Deveer
Journal:  Turk J Obstet Gynecol       Date:  2020-12-10

7.  Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

Authors:  Raoul Orvieto
Journal:  J Ovarian Res       Date:  2013-11-05       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.